MT Educare Limited
MT Educare Limited (MTEDUCARE.NS) Stock Competitors & Peer Comparison
See (MTEDUCARE.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Education & Training Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MTEDUCARE.NS | ₹1.35 | +4.65% | 96.8M | -0.50 | -₹2.68 | N/A |
| NIITMTS.BO | ₹289.70 | -2.93% | 40B | 18.68 | ₹15.61 | +1.03% |
| NIITMTS.NS | ₹290.15 | -2.94% | 39.9B | 18.65 | ₹15.61 | +1.03% |
| CRIZAC.NS | ₹189.60 | -6.36% | 32.5B | 16.93 | ₹10.97 | N/A |
| CRIZAC.BO | ₹189.35 | -6.31% | 32.4B | 16.89 | ₹10.97 | N/A |
| VERANDA.NS | ₹142.10 | +7.86% | 13.1B | 14.10 | ₹9.65 | N/A |
| VERANDA.BO | ₹142.10 | +3.31% | 13B | 14.01 | ₹9.66 | N/A |
| NIITLTD.BO | ₹54.73 | -8.71% | 7.4B | 32.59 | ₹1.67 | +1.84% |
| NIITLTD.NS | ₹54.79 | -8.24% | 7.4B | 32.55 | ₹1.67 | +1.84% |
| GLOBAL.NS | ₹92.56 | -7.02% | 4.7B | 20.79 | ₹4.43 | +1.09% |
Stock Comparison
MTEDUCARE.NS vs NIITMTS.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, NIITMTS.BO has a market cap of 40B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while NIITMTS.BO trades at ₹289.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas NIITMTS.BO's P/E ratio is 18.68. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to NIITMTS.BO's ROE of +0.18%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to NIITMTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check NIITMTS.BO's competition here
MTEDUCARE.NS vs NIITMTS.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, NIITMTS.NS has a market cap of 39.9B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while NIITMTS.NS trades at ₹290.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas NIITMTS.NS's P/E ratio is 18.65. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to NIITMTS.NS's ROE of +0.18%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to NIITMTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check NIITMTS.NS's competition here
MTEDUCARE.NS vs CRIZAC.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, CRIZAC.NS has a market cap of 32.5B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while CRIZAC.NS trades at ₹189.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas CRIZAC.NS's P/E ratio is 16.93. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to CRIZAC.NS's ROE of N/A. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to CRIZAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check CRIZAC.NS's competition here
MTEDUCARE.NS vs CRIZAC.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, CRIZAC.BO has a market cap of 32.4B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while CRIZAC.BO trades at ₹189.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas CRIZAC.BO's P/E ratio is 16.89. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to CRIZAC.BO's ROE of N/A. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to CRIZAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check CRIZAC.BO's competition here
MTEDUCARE.NS vs VERANDA.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, VERANDA.NS has a market cap of 13.1B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while VERANDA.NS trades at ₹142.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas VERANDA.NS's P/E ratio is 14.10. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to VERANDA.NS's ROE of +0.25%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to VERANDA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check VERANDA.NS's competition here
MTEDUCARE.NS vs VERANDA.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, VERANDA.BO has a market cap of 13B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while VERANDA.BO trades at ₹142.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas VERANDA.BO's P/E ratio is 14.01. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to VERANDA.BO's ROE of +0.25%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to VERANDA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check VERANDA.BO's competition here
MTEDUCARE.NS vs NIITLTD.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, NIITLTD.BO has a market cap of 7.4B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while NIITLTD.BO trades at ₹54.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas NIITLTD.BO's P/E ratio is 32.59. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to NIITLTD.BO's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to NIITLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check NIITLTD.BO's competition here
MTEDUCARE.NS vs NIITLTD.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, NIITLTD.NS has a market cap of 7.4B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while NIITLTD.NS trades at ₹54.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas NIITLTD.NS's P/E ratio is 32.55. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to NIITLTD.NS's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to NIITLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check NIITLTD.NS's competition here
MTEDUCARE.NS vs GLOBAL.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, GLOBAL.NS has a market cap of 4.7B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while GLOBAL.NS trades at ₹92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas GLOBAL.NS's P/E ratio is 20.79. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to GLOBAL.NS's ROE of +0.19%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to GLOBAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check GLOBAL.NS's competition here
MTEDUCARE.NS vs APTECHT.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, APTECHT.NS has a market cap of 4.3B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while APTECHT.NS trades at ₹76.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas APTECHT.NS's P/E ratio is 16.26. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to APTECHT.NS's ROE of +0.11%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to APTECHT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check APTECHT.NS's competition here
MTEDUCARE.NS vs APTECHT.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, APTECHT.BO has a market cap of 4.3B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while APTECHT.BO trades at ₹76.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas APTECHT.BO's P/E ratio is 16.22. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to APTECHT.BO's ROE of +0.11%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to APTECHT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check APTECHT.BO's competition here
MTEDUCARE.NS vs CLEDUCATE.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, CLEDUCATE.BO has a market cap of 2.4B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while CLEDUCATE.BO trades at ₹45.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas CLEDUCATE.BO's P/E ratio is -10.98. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to CLEDUCATE.BO's ROE of -0.12%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to CLEDUCATE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check CLEDUCATE.BO's competition here
MTEDUCARE.NS vs CLEDUCATE.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, CLEDUCATE.NS has a market cap of 2.4B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while CLEDUCATE.NS trades at ₹46.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas CLEDUCATE.NS's P/E ratio is -10.86. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to CLEDUCATE.NS's ROE of -0.12%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to CLEDUCATE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check CLEDUCATE.NS's competition here
MTEDUCARE.NS vs GOLDENCREST.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, GOLDENCREST.BO has a market cap of 1.7B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while GOLDENCREST.BO trades at ₹328.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas GOLDENCREST.BO's P/E ratio is 2050.00. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to GOLDENCREST.BO's ROE of +0.01%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to GOLDENCREST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check GOLDENCREST.BO's competition here
MTEDUCARE.NS vs ZEELEARN.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, ZEELEARN.NS has a market cap of 1.6B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while ZEELEARN.NS trades at ₹4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas ZEELEARN.NS's P/E ratio is 15.81. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to ZEELEARN.NS's ROE of +0.05%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to ZEELEARN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check ZEELEARN.NS's competition here
MTEDUCARE.NS vs ZEELEARN.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, ZEELEARN.BO has a market cap of 1.6B. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while ZEELEARN.BO trades at ₹4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas ZEELEARN.BO's P/E ratio is 15.81. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to ZEELEARN.BO's ROE of +0.05%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to ZEELEARN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check ZEELEARN.BO's competition here
MTEDUCARE.NS vs COMPUSOFT.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, COMPUSOFT.NS has a market cap of 978.8M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while COMPUSOFT.NS trades at ₹12.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas COMPUSOFT.NS's P/E ratio is 36.38. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to COMPUSOFT.NS's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to COMPUSOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check COMPUSOFT.NS's competition here
MTEDUCARE.NS vs COMPUSOFT.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, COMPUSOFT.BO has a market cap of 975.6M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while COMPUSOFT.BO trades at ₹12.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas COMPUSOFT.BO's P/E ratio is 36.26. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to COMPUSOFT.BO's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to COMPUSOFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check COMPUSOFT.BO's competition here
MTEDUCARE.NS vs KEERTI.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, KEERTI.NS has a market cap of 733.1M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while KEERTI.NS trades at ₹71.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas KEERTI.NS's P/E ratio is 55.35. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to KEERTI.NS's ROE of +0.29%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to KEERTI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check KEERTI.NS's competition here
MTEDUCARE.NS vs LCCINFOTEC.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, LCCINFOTEC.BO has a market cap of 626.6M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while LCCINFOTEC.BO trades at ₹4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas LCCINFOTEC.BO's P/E ratio is -38.08. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to LCCINFOTEC.BO's ROE of -1.66%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to LCCINFOTEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check LCCINFOTEC.BO's competition here
MTEDUCARE.NS vs LCCINFOTEC.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, LCCINFOTEC.NS has a market cap of 560.8M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while LCCINFOTEC.NS trades at ₹4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas LCCINFOTEC.NS's P/E ratio is -44.30. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to LCCINFOTEC.NS's ROE of -1.66%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to LCCINFOTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check LCCINFOTEC.NS's competition here
MTEDUCARE.NS vs TREEHOUSE.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, TREEHOUSE.NS has a market cap of 361.3M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while TREEHOUSE.NS trades at ₹8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas TREEHOUSE.NS's P/E ratio is -2.22. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to TREEHOUSE.NS's ROE of -0.08%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to TREEHOUSE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check TREEHOUSE.NS's competition here
MTEDUCARE.NS vs TREEHOUSE.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, TREEHOUSE.BO has a market cap of 349.9M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while TREEHOUSE.BO trades at ₹8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas TREEHOUSE.BO's P/E ratio is -2.15. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to TREEHOUSE.BO's ROE of -0.08%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to TREEHOUSE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check TREEHOUSE.BO's competition here
MTEDUCARE.NS vs KEEPLEARN.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, KEEPLEARN.BO has a market cap of 275.6M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while KEEPLEARN.BO trades at ₹1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas KEEPLEARN.BO's P/E ratio is -177.00. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to KEEPLEARN.BO's ROE of -0.03%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to KEEPLEARN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check KEEPLEARN.BO's competition here
MTEDUCARE.NS vs KEEPLEARN.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, KEEPLEARN.NS has a market cap of 269.4M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while KEEPLEARN.NS trades at ₹1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas KEEPLEARN.NS's P/E ratio is -173.00. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to KEEPLEARN.NS's ROE of -0.03%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to KEEPLEARN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check KEEPLEARN.NS's competition here
MTEDUCARE.NS vs GTECJAINX.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, GTECJAINX.NS has a market cap of 208.6M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while GTECJAINX.NS trades at ₹19.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas GTECJAINX.NS's P/E ratio is -23.00. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to GTECJAINX.NS's ROE of -2.60%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to GTECJAINX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check GTECJAINX.NS's competition here
MTEDUCARE.NS vs UMESLTD.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, UMESLTD.BO has a market cap of 176.2M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while UMESLTD.BO trades at ₹6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas UMESLTD.BO's P/E ratio is 51.31. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to UMESLTD.BO's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to UMESLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check UMESLTD.BO's competition here
MTEDUCARE.NS vs UMESLTD.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, UMESLTD.NS has a market cap of 173.8M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while UMESLTD.NS trades at ₹6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas UMESLTD.NS's P/E ratio is 50.62. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to UMESLTD.NS's ROE of +0.02%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to UMESLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check UMESLTD.NS's competition here
MTEDUCARE.NS vs EDUCOMP.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, EDUCOMP.BO has a market cap of 122.5M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while EDUCOMP.BO trades at ₹1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas EDUCOMP.BO's P/E ratio is -0.34. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to EDUCOMP.BO's ROE of +0.00%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to EDUCOMP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check EDUCOMP.BO's competition here
MTEDUCARE.NS vs EDUCOMP.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, EDUCOMP.NS has a market cap of 118.8M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while EDUCOMP.NS trades at ₹0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas EDUCOMP.NS's P/E ratio is -0.33. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to EDUCOMP.NS's ROE of +0.00%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to EDUCOMP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check EDUCOMP.NS's competition here
MTEDUCARE.NS vs MTEDUCARE.BO Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, MTEDUCARE.BO has a market cap of 95.3M. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while MTEDUCARE.BO trades at ₹1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas MTEDUCARE.BO's P/E ratio is -0.49. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to MTEDUCARE.BO's ROE of -9.24%. Regarding short-term risk, MTEDUCARE.NS is less volatile compared to MTEDUCARE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check MTEDUCARE.BO's competition here
MTEDUCARE.NS vs DALALSTCOM.NS Comparison March 2026
MTEDUCARE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTEDUCARE.NS stands at 96.8M. In comparison, DALALSTCOM.NS has a market cap of 0. Regarding current trading prices, MTEDUCARE.NS is priced at ₹1.35, while DALALSTCOM.NS trades at ₹1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTEDUCARE.NS currently has a P/E ratio of -0.50, whereas DALALSTCOM.NS's P/E ratio is -3.06. In terms of profitability, MTEDUCARE.NS's ROE is -9.24%, compared to DALALSTCOM.NS's ROE of +529.59%. Regarding short-term risk, MTEDUCARE.NS is more volatile compared to DALALSTCOM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for MTEDUCARE.NS.Check DALALSTCOM.NS's competition here